ECG also could inhibit the invasion of non-small cell lung cancer (NSCLC) cells by inhibiting the expression of matrix metalloproteinase-2 (MMP-2) and urokinase-type plasminogen activator (uPA) (10). The gene discussed is PLAU; the disease is non-small cell lung carcinoma.